It is unclear if the severity of cardiac involvement in patients with myoto
nic dystrophy (MD) is related to the size of the CTG-repeat expansion. This
open, uncontrolled. observational, prospective study aimed to find out if
there is a relation between the severity of cardiac involvement in MD and t
he CTG-repeat size. In 21 patients with MD, (8 women, 13 men, aged 11-88 ye
ars) a detailed cardiologic examination, including history, clinical examin
ation, electrocardiography (ECG), transthoracic echocardiography and ambula
tory 24-h EGG, was carried out and cardiac involvement was assessed accordi
ng to a previously described scoring system. Additionally, the CTG-repeat s
ize was determined from nuclear DNA of blood leukocytes.
The correlation between the CTG-repeat size and the mean heart rate, PQ-int
erval, QTc-interval, fractional shortening, left ventricular end-diastolic
diameter, septal thickness, posterior wall thickness, mean heart rate on 24
-h ECG and cardiac involvement score was r = 0.47, r = 0.086, r = 0.11, r =
- 0.27, r = - 0.34, r = - 0.06, r = - 0.12, r = 0.16 and r = 0.09 (all p >
0.05), respectively. In patients 21-30, 31-40 and 41-50 years of age, card
iac involvement increased with increasing CTG-repeat size. In younger patie
nts, the number of CTG-repeats needed to develop a reasonable cardiac invol
vement was higher than in older patients. Depending on age, cardiac involve
ment increases with increasing CTG-repeat size obtained from blood leukocyt
es in patients with MD.